ALK and non-small cell lung carcinoma: The existence of HIV infection should not negatively influence the search for other druggable targets, such as anaplastic lymphoma kinase (ALK) rearrangement, already described in PLWH affected by non-small cell lung cancer (NSCLC) [35].